Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Healthcare ETF Vanguard (VHT)

Healthcare ETF Vanguard (VHT)
261.03 x 10 267.35 x 9
Post-market by (Cboe BZX)
265.03 -3.40 (-1.27%) 03/25/25 [NYSE Arca]
261.03 x 10 267.35 x 9
Post-market 265.03 unch (unch) 20:00 ET
Quote Overview for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
263.48
Day High
269.39
Open 269.39
Previous Close 268.43 268.43
Volume 181,700 181,700
Avg Vol 183,545 183,545
Stochastic %K 49.78% 49.78%
Weighted Alpha -2.40 -2.40
5-Day Change -2.10 (-0.79%) -2.10 (-0.79%)
52-Week Range 250.07 - 289.14 250.07 - 289.14
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Vanguard Group
  • Assets Under Management 16,789,796,800
  • Shares Outstanding, K 62,274
  • 60-Month Beta 0.73
  • Price/Earnings ttm 22.00
  • Annual Dividend & Yield 3.99 (1.48%)
  • Most Recent Dividend 0.940 on 03/25/25
  • Management Fee 0.09%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 14.03% ( +1.13%)
  • Historical Volatility 12.21%
  • IV Percentile 71%
  • IV Rank 43.25%
  • IV High 21.32% on 08/05/24
  • IV Low 8.47% on 05/17/24
  • Put/Call Vol Ratio 3.33
  • Today's Volume 39
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 501
  • Open Int (30-Day) 773

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.94 +1.57%
on 03/13/25
Period Open: 272.04
273.72 -3.18%
on 03/03/25
-7.01 (-2.58%)
since 02/25/25
3-Month
252.13 +5.11%
on 12/30/24
Period Open: 257.03
274.19 -3.34%
on 02/05/25
+8.00 (+3.11%)
since 12/24/24
52-Week
250.07 +5.98%
on 12/19/24
Period Open: 265.69
289.14 -8.34%
on 09/03/24
-0.66 (-0.25%)
since 03/25/24

Most Recent Stories

More News
HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom

CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.

HQY : 90.19 (-0.14%)
VHT : 265.03 (-1.27%)
IJH : 60.11 (-0.25%)
VTI : 284.49 (+0.17%)
Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors

The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024.

COMP : 9.43 (-1.87%)
VHT : 265.03 (-1.27%)
$NASX : 18,271.86 (+0.46%)
VDC : 211.60 (-0.80%)
$SPX : 5,776.65 (+0.16%)
VPU : 166.74 (-1.51%)
5 Defensive ETF Strategies to Follow Amid Market Meltdown

Wall Street has suffered a brutal market rout, weighed down by ongoing tariff disputes, surging inflation concerns and growing recessionary fears. The meltdown has erased a staggering $4 trillion in market...

XLU : 76.92 (-1.60%)
BUFR : 30.29 (+0.07%)
VHT : 265.03 (-1.27%)
VIG : 195.98 (-0.26%)
IWD : 189.34 (-0.22%)
BALT : 31.38 (+0.06%)
VTV : 174.03 (-0.30%)
SPYV : 51.41 (-0.04%)
CCOR : 26.19 (-1.06%)
XLP : 78.68 (-0.91%)
DGRO : 61.92 (-0.39%)
Recession Fears Looming? Secure Your Portfolio With These ETFs

President Trump's reciprocal tariffs have weakened U.S. consumer and business sentiment, as consumers grow uncertain about the 'chaotic' U.S. policy, according to Reuters.Global growth concerns have resurfaced...

XLU : 76.92 (-1.60%)
SPHQ : 67.34 (+0.12%)
RSPS : 29.67 (-0.84%)
XLV : 145.27 (-1.28%)
VHT : 265.03 (-1.27%)
QUAL : 174.84 (+0.15%)
QUS : 158.14 (-0.07%)
JQUA : 57.45 (+0.05%)
VDC : 211.60 (-0.80%)
FUTY : 49.70 (-1.58%)
IYH : 60.83 (-1.31%)
VPU : 166.74 (-1.51%)
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates

Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.

VHT : 265.03 (-1.27%)
VTI : 284.49 (+0.17%)
IWM : 207.70 (-0.56%)
OCGN : 0.7147 (+12.13%)
Intuitive Surgical Stock: Is ISRG Outperforming the Healthcare Sector?

Intuitive Surgical's robust outperformance against the healthcare sector over the past year has reinforced Wall Street analysts' bullish outlook on the stock.

VHT : 265.03 (-1.27%)
ABT : 125.60 (-1.27%)
ISRG : 519.81 (+2.21%)
These Vanguard ETFs Show Where the Smart Money Is Moving Now

Don't discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds (ETFs) that are going up -- often works over the short to medium term.

VHT : 265.03 (-1.27%)
KO : 68.81 (-0.20%)
VEU : 62.29 (+0.39%)
MRK : 87.87 (-4.81%)
JNJ : 161.02 (-1.39%)
ABBV : 201.34 (-3.74%)
UNH : 513.43 (-0.59%)
VFMV : 125.52 (-0.05%)
COST : 930.26 (+0.46%)
VEA : 52.40 (+0.54%)
VDC : 211.60 (-0.80%)
EDV : 69.83 (-0.03%)
Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025

The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its scope and diversity. It measures the performance of 500 large-cap companies across all 11...

VHT : 265.03 (-1.27%)
$SPX : 5,776.65 (+0.16%)
VOX : 155.95 (+1.15%)
Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

IJR : 107.36 (-0.60%)
VHT : 265.03 (-1.27%)
HIMS : 37.04 (-0.99%)
VTI : 284.49 (+0.17%)
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

IJR : 107.36 (-0.60%)
VHT : 265.03 (-1.27%)
HIMS : 37.04 (-0.99%)
VTI : 284.49 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Vanguard Health Care ETF seeks to track the performance of the MSCI US Investable Market Health Care 25/50 Index.

See More

Key Turning Points

3rd Resistance Point 274.36
2nd Resistance Point 271.88
1st Resistance Point 268.45
Last Price 265.03
1st Support Level 262.54
2nd Support Level 260.06
3rd Support Level 256.63

See More

52-Week High 289.14
Fibonacci 61.8% 274.21
Fibonacci 50% 269.60
Last Price 265.03
Fibonacci 38.2% 264.99
52-Week Low 250.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals